Daiichi Sankyo and Lilly Receive U.S. FDA Approval for E... ( PARSIPPANY N.J. and INDIANAPOLIS July...)

Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM)

Date:7/10/2009

PARSIPPANY, N.J. and INDIANAPOLIS, July 10 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) approved Effient(TM) (prasugrel) tablets for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndromes who are managed with an artery-opening procedure known as percutaneous coronary intervention (PCI). PCI usually includes the placement of a stent to help keep the artery open.

Effient (pronounced Ef-fee-ent) helps keep blood platelets from sticking together to form clots, which can block an artery. Taking Effient with aspirin after PCI has been shown to reduce the chances of having a cardiac event (such as a heart attack) and stent-related blood clots (known as stent thrombosis) among patients with acute coronary syndromes (ACS), a common cardiovascular condition.

"After more than a decade of research and testing, we are proud to provide this new treatment option to patients with ACS who are managed with PCI," said Takashi Shoda, president and chief executive officer, Daiichi Sankyo Company, Limited. "Our Daiichi Sankyo and Lilly alliance will launch Effient in the U.S. in the coming weeks."

"The FDA approval of Effient is a major step forward in the treatment of acute coronary syndromes," said John Lechleiter, Ph.D., chairman and chief executive officer of Eli Lilly and Company. "The Daiichi Sankyo/Lilly alliance has provided doctors with an important new option that provides greater protection against thrombotic cardiovascular events to help those suffering with ACS who are being managed with PCI."

Effient should be initiated with a loading dose of 60 mg followed by a maintenance dose of 10 mg once daily. In addition, for those
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Daiichi Sankyo, Inc. Celebrates the Growth of Its U.S. Headquarters
2. Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico
3. Daiichi Sankyo, Inc. Awarded Prestigious NCQA Certification for National Under Pressure(TM) Hypertension Management Program
4. Daiichi Sankyo, Inc. Announces Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology
5. Ranbaxy to Bring in Daiichi Sankyo as Majority Partner; Strategic Combination Creates Innovator and Generic Pharma Powerhouse
6. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
7. Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize
8. Lilly Celebrates Its 35th Year as a Supporter of the Indiana Black Expo
9. Lilly Sets Date and Conference Call for Second-Quarter 2009 Financial Results Announcement
10. Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
11. Lilly Declares Third-Quarter Dividend

Post Your Comments:

(Date:5/25/2013)... BC (PRWEB) May 25, 2013 According ... the most beautiful and powerful women that ever lived. ... felt by some of the most powerful men in ... many beauty remedies to keep her skin glowing and ... made with bees- wax, maringa oil and cyprus grass. ...

(Date:5/25/2013)... May 25, 2013 For college ... finals week. Increasingly, they are turning to prescription ... and study. For more on this, go to ... treatment facility, warns that students who pick up ... at risk for developing a physical and psychological ...

(Date:5/25/2013)... May 25, 2013 HealthCrave Medical ... is unique in that it doesn’t just focus ... on treating what causes the noticeable signs of ... Dr. James D. Weiss, M.D., the center provides ... process while helping patients to live longer, healthier ...

(Date:5/24/2013)... A recent study by research group Harris ... upcoming bathing suit season. Almost 138 million people are fearful ... due to weight issues and a quarter admit they feel ... Labs recommends that those anxious about their size consider the ... of an overall effort to improve diet and exercise habits ...

(Date:5/24/2013)... 24, 2013 Compromise is often cited as ... it comes to sleep and comfort. However, many couples find ... individual. For some, this can cause added stress, lost sleep, ... blog, tackles eight common issues in their latest article on ... He Wants Firm: What to do When You Disagree on ...

Breaking Medicine News(10 mins):Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2 Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2 Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2 Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3 Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2

[0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals [0] Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within [0] PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful [0] What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples

... Weight Watchers program and obesity training, state,s,largest Medicaid managed ... Association to provide medical professionals the opportunity to ... in conducting Breathe Well, Live Well program, CHARLESTON, ... among the highest in the country in asthma prevalence,UniCare ...

... and HONOLULU, March 12 Allscripts,the leading ... that physicians use to improve healthcare, today ... that provides,technology and support services to more ... statewide license for the Allscripts Electronic Health,Record ...

... in 30% of middle schoolers studied, blamed on acids ... News) -- Dental erosion -- the loss of the ... the United States, researchers say. , "This study is ... prevalence of dental erosion in this country and, more ...

... March 12 As part of its ongoing ... decision-making,Independence Blue Cross today announced that four area ... Complex and Rare Cancers(SM)., Blue Distinction(R) is ... to make wise health care decisions and to ...

... Campaign Features "Superheroes" Theme, WASHINGTON, March 12 ... Agency for Healthcare Research and Quality,(AHRQ) joined with ... public service campaign designed to encourage,Hispanics to become ... urges,Hispanics to stay healthy for their loved ones ...

... TORONTO, March 12 /PRNewswire-FirstCall/ - Bradmer ... the development and,commercialization of cancer therapies, today ... operational and financial results., Operational Highlights, ... 2007, the Company achieved the,following steps in ...

UniCare of West Virginia Providing Assistance for Asthma Education Training Hawaii's Premier Physician Management Company, TeamPraxis, Selects Allscripts Electronic Health Record for Statewide Deployment Dental Erosion on Rise in U.S.Independence Blue Cross Announces Blue Distinction Centers for Complex and Rare Cancers(SM) in Philadelphia AHRQ and Ad Council Encourage Hispanics to Become More Involved in Their Health Care Bradmer announces 2007 fourth quarter and fiscal year operational and financial results

(Date:5/24/2013)... An international roster of experts on malignant pleural ... Santa Monica, Calif. , to discuss their ... a rare form of cancer that results from exposure ... of the chest. Hosted by UCLA and ... Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural ...

(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer"). On ...

(Date:5/23/2013)... , May 24, 2013 3SBio Inc. ... "Company"), a leading China -based ... marketing biopharmaceutical products, announced today that, at an ... Company,s shareholders voted in favor of the proposal ... and plan of merger dated February 8, 2013, ...

Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2 International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8 Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 2 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3

[0] International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma [0] Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements [0] 3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement

... CHENGDU, China, Jan. 7, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin ... ), a pharmaceutical company that specializes in patented ... other pharmaceuticals today announced that the Company,s 2010 ... New York Stock Exchange Conference Room 632 on Monday, ...

... 2011 Athersys, Inc. (Nasdaq: ATHX ) today ... present at Retail Investor Confrences.com. DATE: , January 11, ... will be a live, interactive online event where investors are ... the presentation hall as well as the company,s "virtual trade ...

Cached Medicine Technology:Tianyin Pharmaceutical to Hold 2010 Shareholder Annual Meeting on March 21, 2011 at NYSE 2 Athersys to Present Live at Retail Investor Conferences.com on January 11th 2

Tianyin Pharmaceutical to Hold 2010 Shareholder Annual Meeting on March 21, 2011 at NYSE Athersys to Present Live at Retail Investor Conferences.com on January 11th

Inquire...

Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....

BD Vacutainer® Fluoride Tubes - Glass...

VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....

Medicine Products:

MONOJECT Grey Stopper VACUETTE Glucose tubes - Non-ridged (pull cap)BD Vacutainer® Fluoride (Glucose) Tubes - Glass VACUETTE Trace Element tubes - Ridged (safety screw cap)